Cancer Screening in the Primary Care Setting. The Role of the Primary Care Physician in Screening for Breast, Cervical, Colorectal, Lung, Ovarian, and Prostate Cancers

Primary Care - Clinics in Office Practice

Volumn 34, Issue 1, 2007, Pages 137-167

  Miser, William F ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CASE FINDING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HEALTH CARE PERSONNEL; HUMAN; HYSTERECTOMY; LUNG CANCER; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OVARY CANCER; PAPANICOLAOU TEST; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND; UTERINE CERVIX CANCER; WART VIRUS;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COUNSELING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; NEOPLASMS; OVARIAN NEOPLASMS; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS; SEX FACTORS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 34247607690     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.02.002     Document Type: Review

References (113)

1. American Cancer Society. Cancer facts and figures, 2007 (2007), American Cancer Society, Atlanta (GA)
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
3. Wender R.C. Preserving primary care: the front line in the war against cancer. CA Cancer J Clin 57 1 (2007) 4-5
4. Ferrante J.M., Gonzalez E.C., Pal N., et al. Effects of physician supply on early detection of breast cancer. J Am Board Fam Pract 13 6 (2000) 408-414
5. Campbell R.J., Ramirez A.M., Perez K., et al. Cervical cancer rates and the supply of primary care physicians in Florida. Fam Med 35 1 (2003) 60-64
6. Roetzheim R.G., Pal N., Gonzalez E.C., et al. The effects of physician supply on the early detection of colorectal cancer. J Fam Pract 48 11 (1999) 850-858
7. Grunfeld E. Cancer survivorship: a challenge for primary care physicians. Br J Gen Pract 55 519 (2005) 741-742
8. Commission on Chronic Illness. Chronic illness in the United States (1957), Commonwealth Fund, Harvard University Press, Cambridge (MA) p. 45
9. Wilson J.M.G., and Jungner F. Principles and practice of screening for disease. Public Health Papers No. 34 (1968), WHO, Geneva
10. nd edition (1985), W.B. Saunders, Philadelphia
11. Gates T.J. Screening for cancer: evaluating the evidence. Am Fam Physician 63 3 (2001) 513-522
12. Alibhai S.M. Cancer screening: the importance of outcome measures. Crit Rev Oncol Hematol 57 3 (2006) 215-224
13. Rembold C.M. Number needed to screen: development of a statistic for disease screening. BMJ 317 7154 (1998) 307-312
14. Schwartz L.M., Woloshin S., Fowler Jr. F.J., et al. Enthusiasm for cancer screening in the United States. JAMA 291 1 (2004) 71-78
15. Campos-Outcalt Sr. D. US Preventive Services Task Force: the gold standard of evidence-based prevention. J Fam Pract 54 6 (2005) 517-519
16. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. Revision 6.2. Available at: http://www.aafp.org/online/en/home/clinical/exam.html. Accessed February 15, 2007.
17. Tudiver F., Guibert R., Haggerty J., et al. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?. J Fam Pract 51 9 (2002) 760
18. Crabtree B.F., Miller W.L., Tallia A.F., et al. Delivery of clinical preventive services in family medicine offices. Ann Fam Med 3 5 (2005) 430-435
19. Pham H.H., Schrag D., Hargraves J.L., et al. Delivery of preventive services to older adults by primary care physicians. JAMA 294 4 (2005) 473-481
20. Walter L.C., and Covinsky K.E. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285 21 (2001) 2750-2756
21. American Geriatric Society. Health screening decisions for older adults: position paper. J Am Geriatr Soc 51 2 (2003) 270-271
22. Humphrey L.L., Helfand M., Chan B.K., et al. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 137 5 Part 1 (2002) 347-360
23. Elmore J.G., Armstrong K., Lehman C.D., et al. Screening for breast cancer. JAMA 293 10 (2005) 1245-1256
24. Gotzsche P.C., and Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 355 9198 (2000) 129-134
25. David S.P. Should we offer routine breast cancer screening with mammography?. Am Fam Physician 68 2 (2003) 260-262
26. US Preventative Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 137 5 Part 1 (2002) 344-346
27. Bartella L., Smith C.S., Dershaw D.D., et al. Imaging breast cancer. Radiol Clin North Am 45 1 (2007) 45-67
28. Warren R., and Eleti A. Overdiagnosis and overtreatment of breast cancer: is overdiagnosis an issue for radiologists?. Breast Cancer Res 8 2 (2006) 205
29. Elmore J.G., Barton M.B., Moceri V.M., et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338 16 (1998) 1089-1096
30. Kerlikowske K., Salzmann P., Phillips K.A., et al. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA 282 22 (1999) 2156-2163
31. Lantz P.M., and Ubel P.A. The use of life expectancy in cancer screening guidelines: moving with caution from model-based evidence to evidence-based guidelines. J Gen Intern Med 20 6 (2005) 552-553
32. Mandelblatt J.S., Schechter C.B., Yabroff K.R., et al. Toward optimal screening strategies for older women: costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med 20 6 (2005) 487-496
33. Parnes B.L., Smith P.C., Conry C.M., et al. Clinical inquiries: when should we stop mammography screening for breast cancer in elderly women?. J Fam Pract 50 2 (2001) 110-111
34. Walter L.C., Lindquist K., and Covinsky K.E. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med 140 9 (2004) 681-688
35. Gaskie S., and Nashelsky J. Clinical inquiries: are breast self-exams or clinical exams effective for screening breast cancer?. J Fam Pract 54 9 (2005) 803-804
36. Barton M.B., Harris R., and Fletcher S.W. The rational clinical examination: does this patient have breast cancer? The screening clinical breast examination: should it be done? How?. JAMA 282 13 (1999) 1270-1280
37. US Preventative Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143 5 (2005) 355-361
38. Lehman C.D. Screening MRI for women at high risk for breast cancer. Semin Ultrasound CT MR 27 4 (2006) 333-338
39. Delille J.P., Slanetz P.J., Yeh E.D., et al. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11 4 (2005) 236-241
40. Moore D.H. Cervical cancer. Obstet Gynecol 107 5 (2006) 1152-1161
41. Feldman S. How often should we screen for cervical cancer?. N Engl J Med 349 16 (2003) 1495-1496
42. Zoorob R., Anderson R., Cefalu C., et al. Cancer screening guidelines. Am Fam Physician 63 6 (2001) 1101-1112
43. Sawaya G.F., McConnell K.J., Kulasingam S.L., et al. Risk of cervical cancer associated with extending the interval between cervical cancer screenings. N Engl J Med 349 16 (2003) 1501-1509
44. US Preventative Services Task Force. Screening for cervical cancer: recommendations and rationale. Am Fam Physician 67 8 (2003) 1759-1766
45. Curran D.R., Stigleman S., and Neher J.O. Clinical inquiries: should we discontinue Pap smear screening in women aged >65 years?. J Fam Pract 53 4 (2004) 308-310
46. Sirovich B.E., and Welch H.G. Cervical cancer screening among women without a cervix. JAMA 291 24 (2004) 2990-2993
47. Stokes-Lampard H., Wilson S., Waddell C., et al. Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature. BJOG 113 12 (2006) 1354-1365
48. Andy C., Turner L.F., and Neher J.O. Clinical inquiries: is the ThinPrep better than conventional Pap smear at detecting cervical cancer?. J Fam Pract 53 4 (2004) 313-315
49. Nuovo J., Melnikow J., and Howell L.P. New tests for cervical cancer screening. Am Fam Physician 64 5 (2001) 780-786
50. Mandelblatt J.S., Lawrence W.F., Womack S.M., et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287 18 (2002) 2372-2381
51. Gollub M.J., Schwartz L.H., and Akhurst T. Update on colorectal cancer imaging. Radiol Clin North Am 45 1 (2007) 85-118
52. Podolsky D.K. Going the distance: the case for true colorectal cancer screening. N Engl J Med 343 3 (2000) 207-208
53. US Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Available at: http://www.ahrq.gov/clinic/3rdupstf/colorectal/colorr.pdf. Accessed February 15, 2007.
54. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 9040 (1996) 1472-1477
55. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 9040 (1996) 1467-1471
56. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 19 (1993) 1365-1371
57. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 22 (2000) 1603-1607
58. Jorgensen O.D., Kronborg O., and Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50 1 (2002) 29-32
59. Moayyedi P., and Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 101 2 (2006) 380-384
60. Collins J.F., Lieberman D.A., Durbin T.E., et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 142 2 (2005) 81-85
61. Boggs B.D., Stephens M.M., and Wallace R. Clinical inquiries: how does colonoscopy compare with fecal occult blood testing as a screening tool for colon cancer?. J Fam Pract 54 11 (2005) 996-997
62. Stokamer C.L., Tenner C.T., Chaudhuri J., et al. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 20 3 (2005) 278-282
63. Cronau H. Preventive cancer care in men: an overview. Family Practice Recertification 27 8 (2005) 35-43
64. Pignone M., Rich M., Teutsch S.M., et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 137 2 (2002) 132-141
65. Wender R.C. Colorectal cancer screening: don't just do it, do it right. Am Fam Physician 73 10 (2006) 1707-1708
66. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 2 (2005) 86-94
67. Gohagan J.K., Prorok P.C., Hayes R.B., et al. The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 21 6 Suppl (2000) 251S-272S
68. Weissfeld J.L., Schoen R.E., Pinsky P.F., et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 97 13 (2005) 989-997
69. Lieberman D.A., Weiss D.G., Bond J.H., et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 3 (2000) 162-168
70. Ahluwalia J., Miser W., and Bova J.G. Virtual colonoscopy: what is its role in cancer screening?. J Fam Pract 56 3 (2007) 186-191
71. Winawer S.J., Stewart E.T., Zauber A.G., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy: National Polyp Study Work Group. N Engl J Med 342 24 (2000) 1766-1772
72. Taylor W.C. A 71-year-old woman contemplating a screening colonoscopy. JAMA 295 10 (2006) 1161-1167
73. Fletcher R.H. The end of barium enemas?. N Engl J Med 342 24 (2000) 1823-1824
74. Seeff L.C., Shapiro J.A., and Nadel M.R. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 51 9 (2002) 761-766
75. Cokkinides V.E., Chao A., Smith R.A., et al. Correlates of underutilization of colorectal cancer screening among US adults, age 50 years and older. Prev Med 36 1 (2003) 85-91
76. Ioannou G.N., Chapko M.K., and Dominitz J.A. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98 9 (2003) 2082-2091
77. Nadel M.R., Blackman D.K., Shapiro J.A., et al. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med 35 3 (2002) 199-206
78. Sirovich B.E., Schwartz L.M., and Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA 289 11 (2003) 1414-1420
79. Walsh J. Colorectal cancer screening: the time is now!. J Gen Intern Med 20 11 (2005) 1068-1070
80. Greiner K.A., Born W., Nollen N., et al. Knowledge and perceptions of colorectal cancer screening among urban African Americans. J Gen Intern Med 20 11 (2005) 977-983
81. Wee C.C., McCarthy E.P., and Phillips R.S. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41 1 (2005) 23-29
82. Tatum P., Mehr D., and Easton B. Clinical inquiries: at what age do patients no longer need colorectal cancer screening?. J Fam Pract 50 7 (2001) 575-576
83. US Preventive Services Task Force. Colon cancer screening (USPSTF recommendation). J Am Geriatr Soc 48 3 (2000) 333-335
84. Gross C.P., McAvay G.J., Krumholz H.M., et al. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 145 9 (2006) 646-653
85. Ginsberg M.S., Grewal R.K., and Heelan R.T. Lung cancer. Radiol Clin North Am 45 1 (2007) 21-43
86. Humphrey L.L., Teutsch S., and Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the US Preventive Services Task Force. Ann Intern Med 140 9 (2004) 740-753
87. Chek K., Tribuna J., and Nashelsky J. Clinical inquiries: is yearly chest x-ray screening helpful in reducing mortality for smokers?. J Fam Pract 54 9 (2005) 815-816
88. Bach P.B., Kelley M.J., Tate R.C., et al. Screening for lung cancer: a review of the current literature. Chest 123 1 Suppl (2003) 72S-82S
89. Marcus P.M., Bergstralh E.J., Fagerstrom R.M., et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92 16 (2000) 1308-1316
90. Oken M.M., Marcus P.M., Hu P., et al. Baseline chest radiograph for lung cancer detection in the randomized prostate, lung, colorectal and ovarian cancer screening trial. J Natl Cancer Inst 97 24 (2005) 1832-1839
91. Gohagan J.K., Marcus P.M., Fagerstrom R.M., et al. Final results of the lung screening study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47 1 (2005) 9-15
92. US Preventative Services Task Force. Lung cancer screening: recommendation statement. Ann Intern Med 140 9 (2004) 738-739
93. Bach P.B., Niewoehner D.E., and Black W.C. Screening for lung cancer: the guidelines. Chest 123 1 Suppl (2003) 83S-88S
94. Hillman B.J., and Schnall M.D. American College of Radiology Imaging Network: future clinical trials. Radiology 227 3 (2003) 631-632
95. US Preventative Services Task Force. Screening for ovarian cancer: recommendation statement. Ann Fam Med 2 3 (2004) 260-262
96. Mironov S., Akin O., Pandit-Taskar N., et al. Ovarian cancer. Radiol Clin North Am 45 1 (2007) 149-166
97. Wiseman P.M., Puglia K., and Beck E. Clinical inquiries: should we screen for ovarian cancer?. J Fam Pract 52 12 (2003) 981-984
98. Stewart R.A., and Thistlethwaite J. Routine pelvic examination for asymptomatic women: exploring the evidence. Aust Fam Physician 35 11 (2006) 873-877
99. ACOG Committee. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Obstet Gynecol 100 6 (2002) 1413-1416
100. Kyrgiou M., Tsoumpou I., Martin-Hirsch P., et al. Ovarian cancer screening. Anticancer Res 26 6C (2006) 4793-4801
101. Buys S.S., Partridge E., Greene M.H., et al. Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 193 5 (2005) 1630-1639
102. National Institutes of Health. Consensus development conference statement: ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 55 3 Pt 2 (1994) S4-S14
103. Akin O., and Hricak H. Imaging of prostate cancer. Radiol Clin North Am 45 1 (2007) 207-222
104. Ilic D., O'Connor D., Green S., et al. Screening for prostate cancer. Cochrane Database Syst Rev 3 (2006) CD004720
105. Schwartz K., Deschere B., and Xu J. Screening for prostate cancer: who and how often?. J Fam Pract 54 7 (2005) 586-596
106. US Preventative Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med 137 11 (2002) 915-916
107. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology 14 2 (2000) 267-272 77-8, 80
108. McNaughton-Collins M., Fowler Jr. F.J., Caubet J.F., et al. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 117 10 (2004) 719-725
109. Andriole G.L., Levin D.L., Crawford E.D., et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 97 6 (2005) 433-438
110. Schapira M.M., and VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract 49 5 (2000) 418-424
111. Ross K.S., Carter H.B., Pearson J.D., et al. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. JAMA 284 11 (2000) 1399-1405
112. Lu-Yao G., Stukel T.A., and Yao S.L. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 95 23 (2003) 1792-1797
113. Welch H.G. Informed choice in cancer screening. JAMA 285 21 (2001) 2776-2778